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Communicated by N.Hastie
We have cloned and sequenced mouse cDNAs corre-
sponding to a third member of a family of melanocyte-
specific mRNAs, which encode tyrosinase and related
proteins. This new member, tyrosinase-related protein-2
(TRP-2), has -40% amino acid identity with the two
other proteins in the family and has the same structural
features including two copper binding sites, two cysteine-
rich regions, a signal peptide and a transmembrane
domain. We now show that one of the cysteine-rich
regions in this protein family is an 'EGF-like' repeat
found in many extraceliular and cell surface proteins. The
gene encoding TRP-2 maps to mouse chromosome 14,
in the region of the coat colour mutation slaty. We show
that the TRP-2 of slay mice has a single amino acid
difference from wild-type TRP-2; a substitution of
glutamine for arginine in the first copper binding site.
TRP-2 is the much sought melanogenic enzyme
DOPAchrome tautomerase (DT), which catalyses the
conversion of DOPAchrome to 5,6,dihydroxyindole-2-
carboxylic acid. Extracts from mice homozygous for the
slaty mutation have a 3-fold or more reduction in DT
activity, indicating that TRP-2/DT is encoded at the slaty
locus, and the missense mutation reduces but does not
abolish the enzyme activity.
Key words: DOPAchrome tautomerase/melanocytes/mouse
genetics/mutations/pigmentation
Introduction
Mutations at numerous loci affecting mouse hair colour have
been invaluable in dissecting the developmental processes
leading to pigment production by melanocytes (Silvers, 1979;
Jackson, 1985, 1991). Several of these pigmentation genes
have many mutant alleles, resulting from the specific locus
mutation tests (Russell, 1951; Searle, 1974). Recombinant
cDNAs have been cloned from three of these six specific
loci, namely dilute, albino and brown. The first of these
encodes a novel myosin heavy chain protein, involved in
melanocyte shape and pigment distribution (Mercer et al.,
1991). The other two encode proteins related to each other.
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The albino locus on mouse chromosome 7 encodes the
enzyme tyrosinase (Muller et al., 1988; Kwon et al., 1989;
Takeda et al., 1989; Yamamoto et al., 1989) a melanocyte-
specific enzyme which converts tyrosine to 3,4-dihydroxy-
phenylalanine (DOPA), DOPA to DOPAquinone and
possibly also 5,6-dihydroxyindole to indole-5,6-quinone
(Korner and Pawelek, 1982). Deletions or point mutations
in the tyrosinase gene give rise to loss or reduction of enzyme
activity, and thus to complete or partial loss of all pigment
(Jackson and Bennett, 1990; Shibahara et al., 1990;
Yokoyama et al., 1990). Mice homozygous for the albino
mutation can be restored to wild-type phenotype by
transgenic insertion of the wild-type tyrosinase gene (Tanaka
et al., 1990; Yokoyama et al., 1990).
A protein with - 36% amino acid identity to tyrosinase,
termed tyrosinase-related protein-1 (TRP-1), was initially
isolated as a candidate for tyrosinase (Shibahara et al., 1986).
Subsequent mapping and functional studies showed that
TRP- I maps to the brown locus on chromosome 4 (Jackson,
1988; Muller et al., 1988) whereas tyrosinase is encoded
by the albino locus on chromosome 7. At the brown locus
deletions or null point mutations do not eliminate
pigmentation, but result in mice with brown, instead of black
eumelanin (Zdarsky et al., 1990). Other mutations at this
locus result in an intermediate phenotype, between black and
brown, due to a reduction in the amount of TRP-1 mRNA,
whilst still others have a dominant phenotype resulting in
premature melanocyte death (Jackson et al., 1990).
Homozygous brown melanocytes in culture can be restored
to wild-type pigmentation by the introduction of the wild-
type TRP-1 sequence in a recombinant retrovirus (Bennett
et al., 1990).
A cDNA, termed 5A, was previously identified by
screening of a melanocyte cDNA expression library with
anti-tyrosinase antibodies (Jackson, 1988). The clone shows
some cross-hybridization with pMT4, a TRP-1 cDNA clone,
but encodes a different protein, which we term TRP-2
(tyrosinase-related protein-2). We report here the sequence
of TRP-2, which is homologous to TRP-1 and tyrosinase
and retains many of the features common to these two
proteins. Antibodies to the C-terminal portion of TRP-2
detect a protein in melanocytes and melanoma of both mouse
and humans. The protein has DOPAchrome tautomerase
(DT) activity (see Discussion and Tsukamoto et al., 1992).
Genetic mapping using an interspecific backcross indicates
that the gene is unlinked to either previously described locus,
and is located distally on chromosome 14 at or near to a
pigmentation locus called slaty (slt). The sequence of TRP-2
from slaty mice shows a single base (and single amino acid)
difference from wild-type, located within one of the putative
copper binding sites of the protein. The change results in
a 3- to 4-fold decrease in DT activity, and a consequent
change in the pigmentation of the mutant mice to a dark
grey/brown eumelanin.
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Results
Isolation and sequencing of TRP-2 cDNA
Previously we have screened a B16 mouse melanoma cell
cDNA library cloned into the expression vector Xgtl 1 with
two rabbit antisera; one raised against mouse tyrosinase, the
other against hamster tyrosinase. A clone (SA) was identified
which was detected by both sera (Jackson, 1988). This clone
hybridized at low stringency to the TRP-1 cDNA clone
pMT4. However, 5A detected a different set of DNA
fragments on Southern blot hybridization, and a slightly
different sized melanocyte-specific mRNA species on
Northern blot hybridization, and thus represents a different
but related cDNA which we call TRP-2. We determined the
DNA sequence of the complete 1180 bp cloned insert, which
is a partial-length cDNA. Using a deletion subclone
containing the 5'-terminal 330 bp we rescreened the cDNA
library by hybridization. Five strongly positive clones were
analysed. Three contain the same 1700 bp EcoRI fragment,
but also contain an additional, smaller fragment. The clone
containing the longest additional fragment (450 bp) was
selected and both EcoRI fragments subcloned. We
determined the DNA sequence of these fragments, by
making and sequencing nested deletion derivatives.
Subsequently we synthesized oligonucleotides which enabled
sequence priming throughout the length of the coding region,
which were used to confirm the sequence (see Materials and
methods). The complete sequence shown in Figure 1 is
compiled from the sequence of both cDNA clones, and
confirmed by direct sequencing of PCR-amplified cDNA.
(Each cDNA clone contained a single base pair variant from
the authentic wild-type sequence determined from the PCR
products.)
Also in Figure 1 is the translation of the amino acid
sequence of TRP-2. The ATG initiation codon shown is the
N-terminal end of the longest open reading frame. Within
the first 200 bp of the 5'-untranslated sequence there are
five ATG triplets, all of which are followed within 40 bp
by an in-frame termination codon. Furthermore, comparison
of the predicted protein sequence with translation of
tyrosinase and TRP-1 mRNAs suggests that the N-terminus
of the primary translation product of TRP-2 should be at
the position indicated. Tyrosinase is known to be a
membrane-inserted protein. Like tyrosinase and TRP-1,
TRP-2 has both a N-terminal leader sequence and a potential
transmembrane domain near the C-terminus, both shown in
Figure 1. The '-1,-3' rule of von Heijne (1986) predicts that
cleavage of the signal sequence should take place between
the alanine and glutamine residues where indicated. This
position is equivalent to the putative signal peptide cleavage
sites of tyrosinase and TRP- 1. There are 15 cysteine residues
in conserved positions between tyrosinase, TRP-1 and
TRP-2. These are circled in Figure 1. In addition TRP-2
has seven putative glycosylation sites of the form NXS or
NXT. Of these, three are in conserved positions in both other
family members and the other four are found in either
tyrosinase or TRP-1. The C-terminal peptide used to raise
antibodies is boxed.
Mapping of Tyrp-2 gene
In accord with mouse nomenclature rules we have named
the gene encoding TRP-2, Tyrp-2. We chromosomally
localized Tyrp-2, by analysing interspecific backcross
progeny derived from the matings of
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[(C57BL/6JXM.spretus)FI xC57BL/6J] mice. This
interspecific backcross mapping panel has been typed for
well over 800 loci that are well distributed among all the
autosomes as well as the X chromosome (Copeland and
Jenkins, 1991). C57BL/6J and M.spretus DNAs were
digested with several enzymes and analysed by Southern blot
hybridization for informative restriction fragment length
variants using the Tyrp-2 probe. The 7.6, 4.1 and 2.0 kb
M. spretus-specific PvuII fragments (see Materials and
methods) were used to follow the segregation of the Tyrp-2
locus in backcross mice. The mapping results indicated that
Tyrp-2 is located in the distal region of mouse chromosome
14. The other markers included in this study are Bmp-J, hr
and D14EhlJ. Although 155 mice were analysed for every
marker and are shown in the segregation analysis (Figure 2),
up to 192 mice were typed for some markers. Each locus
was analysed in pairwise combinations for recombination
frequencies using the additional data. The ratios of the total
number of mice analysed for each pair of loci and the most
likely gene order is:
centromere-Bmp-J - 1/166-hr- 10/192 -D14Eh1] -39/
190- Tyrp-2.
The recombination frequencies [expressed as genetic
distances in centiMorgans (cM) the standard error] are:
Bmp-]-0.6 a 0.6-hr-5.2 + 1.6-D14EhlJ-20.0 +
2.9- Tyrp-2.
We have compared our interspecific mouse backcross map
of chromosome 14 with the composite mouse linkage map
compiled by M.T.Davisson, T.H.Roderick, A.L.Hillyard
and D.P.Doolittle and provided from GBASE, a
computerized database maintained at the The Jackson
Laboratory, Bar Harbor, Maine. The region of chromosome
14 20-25 cM distal to hr contains three pigmentation genes.
One, s, is a recessive spotting mutation, defective in
melanocyte migration. Another, Rn, is a semi-dominant
mutation which results in non- or partially pigmented hairs.
The third is slaty, a recessive mutation which uniformly
affects the eumelanin, so that on a non-agouti background,(in which the hairs are pigmented only with eumelanin) the
mice are a dark grey/brown colour rather than black . In
view of the brown phenotype resulting from mutations of
TRP-1, we took slaty to be the best candidate for a mutation
of TRP-2.
Expression and sequence of the slaty TRP-2 mRNA
The slaty mutation arose spontaneously on a non-inbred
background. We obtained mice from The Jackson
Laboratory in which the mutation had been backcrossed onto
the C57BL/6J background. We prepared RNA from the skin
of 5 day old homozygous slaty mice. Northern blot
hybridization, probed with the TRP-2 cDNA shows that the
amount of TRP-2 mRNA in the slaty mice is the same as
in the wild-type C57BL/6 (Figure 3a).
We therefore used PCR to amplify the whole coding region
of the TRP-2 cDNA made from the skin RNA, and purified
the 1700 bp fragment by gel electrophoresis. Pairs of primers
were used in PCR on the fragment to amplify overlapping
400-500 bp fragments of the cDNA which were sequenced
directly with the priming oligonucleotides and with internal
primers (see Materials and methods).
A single base pair difference only was found between the
slaty TRP-2 coding region and the wild-type sequence in
Figure 1. This is a G to A transition at base 985 which results
Tyrosinase-related protein-2 is the slaty gene product
in a change in codon 194, changing the wild-type arginine in the dinucleotide CpG. This dinucleotide is the common
residue to glutamine. Figure 3b shows the sequence in the site of methylation of mammalian DNA and spontaneous
region of this change. The transition has occurred at a G mutations very frequently occur at these sites, most likely
1 GCAGCATAATAAGCAGTATGGCTGGAGCACTCTGTAAATTAACTCAATTAGACAGAGCCT 60
61 GATTTAACAAGGAAGACTGGCGAGAAGCTCCCCTCATTAAACCTGATGTTAGAGGAGCTT 120
121 CGGATGAAATTAAATCAGTGTTAGTTGTTTGAGTCACATAAAATTGCATGAGCGTGTACA 180
181 CATGTGCACACGTGTAGGCTCTGTGATTTAGGTGGGAATTTTGAGAGGAGAGGAAAGGGC 240
241 TAGAACTAAACCCAAAGAAAAGGAAAGAAGAGAAGAGGAAAGGAAAGAAAAAAGAAAAGG 300
301 CAATTTGAGTGAGTAAAGGTTCCAGAACTCAGGAGTGGAAGACAAGGAGTAAAGTCAGAC 360
361 AGAAACCAGGTGGGACGCCGGCCAGGCCTCCCAATTAAGAAGGCATGGGCCTTGTGGGAT 420
M G L V G W
421 GGGGGCTTCTGCTGGGTTGTCTGGGCTGCGGAATTCTGCTCAGAGCTCGGGCTCAGTTTC 480G L L L G C L G C G I L L R A R A Q F P
................----.
.---..------...--..------:. ..: .
481 CCCGAGTCTGCATGACCTTGGATGGCGTGCTGAACAAGGAA GC GCCCGCCTCTGGGTC 540
R V M T L D G V L N K ELP P L G P
541 CCGAGGCAACCAACATC,SGTGGATTTCTAGAGGGCAGGGGGCAG_GCGCAGAGGTGCAAA 600E A T N I W G F L E G R G Q () A E V Q T
601 CAGACACCAGACCCTGGAGTGGCCCTTATATCCTTCGAAACCAGGATGACCGTGAGCAAT 660
D T R P W S G P Y I L R N Q D D R E Q W
661 GGCCGAGAAiATTCTTCAACGGACAG 720
P R K F F N R T (D K ( T G N F A G Y N(s)
721 GTGGAGGCIGCAAGTTCGGCTGGACCGGCCCCGAC GTAATCGGAAGAAGCCGGCCATCC 780
G G ()K F G W T G P D (D N R K K P A I L
781 TAAGACGGAATATCCATTCCCTGACTGCCCAGGAGAGGGAGCAGTTCTTGGGCGCCTTAG 840
R R N I H S L T A Q E R E Q F L G A L D
841 ACCTGGCCAAGAAGAGTATCCATCCAGACTACGTGATCACCACGCAACACTGGCTGGGGC 900
L A K K S I H P D Y V I TT Q H W L G L
901 TGCTCGGACCCAACGGGACCCAGCCCCAGATCGCCAACTGCAGCGTGTATGACTTTTTTG 960
L G P N G T Q P Q I A N C S V Y D F F V
961 TGTGGCTCCATTATTATTCTGTTCGAGACACATTATTAGGTCCAGGACGCCCCTATAAGG 1020W L H Y Y S V R D T L L G P G R P Y K A
1021 CCATTGATTTCTCTCACCAAGGGCCTGCCTTTGTCACGTGGCACAGGTACCATCTGTTGT 1080
I D F S H Q G P A F V T W H R Y H L L W
1081 GGCTGGAAAGAGAACTCCAGAGACTCACTGGCAATGAGTCCTTTGCGTTGCCCTACTGGA 1140L E R E L Q R L T G N E S F A L P Y W N
1141 ACTTTGCAACCGGGAAGAACGAGT-GTGACGTGIGCACAGACGACTGGCTTGGAGCAGCAA 1200F A T G K N E W D V() T D D W L G A A R
1201 GACAAGATGACCCAACGCTGATTAGTCGGAACTCGAGATTCTCTACCTGGGAGATTGTG' 1260Q D D P T L I S R N S R F S T W E I V )
1261 GCGACAGCTTGGATGACTACAACCGCCGGGTCACACTGXGTAATGGAACCTATGAAGGTT 1320D S L D D Y N R R V T L ) N G T Y E G L
1321 TGCTGAGAAGAAACAAAGTAGGCAGAAATAATGAGAAACTGCCAACCTTAAAAAATGTGC 1380L R R N K V G R N N E K L P T L K N V Q
1381 AAGATIGCCTGTCTCTCCAGAAGTTTGACAGCCCTCCCTTCTTCCAGAACTCTACCTTCA 1440
D W L S L Q K F D S P P F F Q N S T F S
1441 GCTTCAGGAATGCACTGGAAGGGTTTGATAAAGCAGACGGAACACTGGACTCTCAAGTCA 1500F R N A L E G F D K A D G T L D S Q V M
1501 TGAACCTTCATAACTTGGCTCACTCCTTCCTGAATGGGACCAATGCCTTGCCACACTCAG 1560
N L H N L A H S F L N G T N A L P H S A
1561 CAGCCAACGACCCTGTGTTTGTGGTCCTCCACTCTTTTACAGACGCCATCTTTGATGAGT 1620
A N D P V F V V L H S F T D A I F D E W
1621 GGCTGAAGAGAAACAACCCTTCCACAGATGCCTGGCCTCAGGAACTGGCACCCATTGGTC 1680L K R N N P S T D A W P O E L A P I G H
1681 ACAACCGAATGTATAACATGGTCCCCTTCTTCCCACCGGTGACTAATGAGGAGCTCTTCC 1740N R M Y N M V P F F P P V T N E E L F L
1741 TAACCGCAGAGCAACTTGGCTACAATTACGCCGTTGATCTGTCAGAGGAAGAAGCTCCA- 1800T A E Q L G Y N Y A V D L S E E E A P V
1801 TTTGGTCCACAACTCTCTCAGTGGTCATTGGAATCCTGGGAGCTTTCGTCTTGCTCTTGG 1860
W S T T L S V V I G I L G A F V L L L G
1861 GGTTGCTGGCTTTTCTTCAATACAGAAGG CTTCGCAAAGGCTATGCGCCCTTAT G 1920L L A F L Q Y R R L R K G Y A P L M E T
1921 CAGGTCTCAGCAGCAAGAGATACACGGAGGAAGCCTAGCATGCTCCTACCTGGCCTGACC 1980
G L SSK R Y TEE A
1981 TGGGTAGTAACTAATTACACCGTCGCTCATCTTGAGACAGGTGGAACTCTTCAGCGTGTG 2040
2041 CTCTTTAGTAGTGATGATGATGATGCCTTAGCAATGACAATTATCTCTAGTTGCTGCTTT 2100
2101 GCTTATTGTACACAGACAAAATGCTTGGGTCATTCACCACGGTCAAAGTAAGGTGTGGCT 2160
2161 AGTATATGTGACCTTTGATTAG 2182
Fig. 1. Sequence of TRP-2 cDNA. The presumed full-length open reading frame is shown below the DNA sequence. All 15 cysteine residues(enclosed by circles) are conserved across the whole tyrosinase-related family. The N-terminal signal sequence is underlined with a dotted line, and
the hydrophobic transmembrane domain has a solid underline. The boxed C-terminal 14 residue peptide (PEP8) was used to raise anti-TRP-2
antiserum. These sequence data are available from EMBL/GenBank/DDBJ under accession number X63349.
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Fig. 2. Position of the Tyrp-2 locus on mouse chromosome 14. Tyrp-2
was placed on chromosome 14 by interspecific backcross analysis. The
segregation patterns of Tyrp-2 and flanking genes in 155 backcross
animals that were typed in common for Tyrp-2 is shown at the top of
the figure. For each individual pair of loci, more than 155 animals
were typed (see text). Each column represents the chromosome
identified in the backcross progeny that was inherited from the
(C57BL/6JXM.spretus) F1 parent. The shaded boxes represent the
presence of a C57BL/6J allele, and white boxes represent the presence
of a M.spretus allele. The number of offspring inheriting each type of
chromosome is listed at the bottom of each column. Gene order
between Bmp-J and hr was determined by the analysis of additional
mice, not typed for D14EhlJ and Tyrp-2. These studies have been
reported (Ceci et al., 1990). A partial chromosome 14 linkage map
showing the location of Tyrp-2 in relation to linked genes is shown at
the bottom of the figure. Recombination distances between loci in cM
are shown to the left of the chromosome and the position of Bmp-J on
human chromosomes is shown to the right. Human chromosomal
assignments for the other loci have not been obtained.
by the deamination of the methyl-C resulting in a T:G pair
which, on replication can result in the substitution of G by
A. The mutation destroys a TaqI restriction site. To show
that the mutation is present in slaty cDNA we used PCR
to amplify a 320 bp segment ofcDNA from slaty skin, from
two wild-type skin cDNAs (C57BL/6 and BALB/c) and from
the B16 melanoma cell line from which the TRP-2 cDNA
was initially cloned. Figure 3c shows that the TaqI site is
present in the wild-type strain cDNAs but is absent from
the TRP-2 transcript of slaty mice.
Expression and function of wild-type and slaty TRP-2
Antibodies were raised in rabbits against a peptide (PEP8)
consisting of the C-terminal 14 amino acids of TRP-2
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Fig. 3. The slaty mutant TRP-2. (a) Northern blot hybridization
analysis of total skin RNA from neonatal C57BL/6J (left) and
homozygous slaty (right) neonatal mice, probed with labelled TRP-2
cDNA. Equal amounts (10 Ag) of RNA were loaded in each lane, and
equal loading confirmed by ethidium bromide staining of a duplicate
gel. (b) Sequence of cDNA and predicted protein in the region of the
slaty mutation. DNA sequence shown is from bases 978 to 992, and
the amino acids are from 192 to 196. The slaty mutant base (base 985
G to A) is below the sequence, and the resulting amino acid change
(residue 194 R to Q) is above. The TaqI site which is lost in the slaty
sequence is underlined. (c) PCR analysis of cDNA from total neonatal
skin RNA. Lane 1, undigested PCR product; lane 2, TaqI-digested
B16 melanoma cDNA; lane 3, TaqI-digested homozygous slaty
neonatal skin cDNA; lane 4, TaqI-digested C57BL/6J neonatal skin
cDNA; lane 5, TaqI-digested BALB/c neonatal skin cDNA.
coupled to BSA (Figure 1 and Tsukamoto et al., 1992). The
antiserum detects a 75 000 molecular weight glycoprotein
in wild-type mouse melan-a melanocytes and B16 melanoma
cells (Figure 4A). This size is larger than that predicted from
the open reading frame in Figure 1, and is accounted for
by glycosylation of the primary translation product, in
common with tyrosinase and TRP-1. A 55 000 molecular
weight precursor polypeptide can also be detected. The
recognition of these peptides by anti-PEP8 sera confirms that
the open reading frame as shown is expressed. These proteins
are also detectable in human MNT1 melanoma cells
(Figure 4A). A thorough characterization of the aPEP8
serum is described in Tsukamoto et al. (1992)
Extracts from the eyes of neonatal wild-type (C57BL6/J),
albino (BALB/c) and slaty (congenic with C57BL/6J) mice
were examined by Western blotting using the aPEP8
antibody to detect TRP-2. Eyes contain the retinal epithelium
layer, which is made up of melanocytes, and therefore
contain the melanogenic enzymes. The amount of TRP-2
immunoreactive protein detected in slaty mice is highly
variable, sometimes being undetectable and at other times
Tyrosinase-related protein-2 is the slaty gene product
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Fig. 4. Expression of TRP-2/DT protein. (A) Immunopreciptation of labelled peptides from wild-type mouse melanocytes (melan-a), wild-type mouse
melanoma (B16 FIO) and human melanoma (MNT 1) cells. Precipitations were carried out using normal rabbit serum (NRS) or antibodies
specifically directed against the C-terminus of TRP-2 (aPEP8). The arrows indicate the unglycosylated precursor peptide of 55 kDa and the mature,
glycosylated form of 75 kDa both seen in the csPEP8 lanes, but not the NRS. (B) Western blot detection of TRP-2/DT in eye extracts of albino,
black (wild-type, C57BL/6J) and slaty (congenic with C57BL/6J) nice, reacted with normal rabbit serum (NRS) and with antibodies against the C-
terminal peptide of TRP-2 (atPEP8).
being close to the amount seen in wild-type eyes. Figure 4B
is a Western blot, in which TRP-2 is visualized in extracts
from the three strains, showing that the protein detected in
slaty mice is the same size as wild-type.
The protein precipitated by the cuPEP8 serum has
DOPAchrome tautomerase (DT) activity (Tsukamoto et al.,
1992). DT is an enzyme, previously known as DOPAchrome
conversion factor, DOPAchrome oxidoreductase or
DOPAchrome isomerase (Korner and Pawelek, 1980;
Murray et al., 1983; Barber et al., 1984; Aroca et al., 1990;
Pawelek, 1990) which participates in melanin synthesis by
converting DOPAchrome to 5,6,-dihydroxyindole carboxylic
acid (DHICA). It has until now been only partially
characterized. We propose that TRP-2 is DT, and will refer
to it hereafter as TRP-2/DT.
Eye extracts from the same three strains examined in
Figure 4B were assayed for enzyme activity. Table I
summarizes the tyrosinase and DT activity from the three
strains. The DT activity in slaty eyes is somewhat variable,
but is consistently lower than in wild-type or albino extracts
and the mean is less than one-third wild-type. Furthermore,
the extraction of enzyme activity appears to be influenced
by the melanin synthesized. The melanogenic enzymes are
localized within the melanosomes, where melanin is
synthesized and deposited. The enzymes become coated with
melanin during its synthesis, and therefore more difficult to
extract. This is seen as a higher yield of DT from albino
eyes (without melanin) than black eyes (with wild-type
melanin), and a higher recovery of tyrosinase from the slaty
eyes compared with wild-type. The tyrosinase difference
cannot be due to differences other than near the slaty locus
as the slaty mice and wild-type are congenic. We may
therefore take tyrosinase activity as a measure of enzyme
extraction efficiency, and hence the relative activity of DT
in slaty compared with wild-type falls to < 10%. This
correlation between the point mutation in the TRP-2/DT
protein in slaty mice and the decrease in DT activity in the
Table I. Tyrosinase and DOPAchrome tautomerase activity in extracts
of wild-type, albino and slaly tissues
Description Tyrosinase (pmol/4g/h) DT (pmol/4g/h)
Buffer control 0.0 0.0
slaty liver 0.03 ± 0.02 (n = 4) 0.00 + 0.00 (n = 2)
Black eye 0.29 ± 0.06 (n = 6) 1.75 + 0.65 (n = 4)
albino eye 0.01 + 0.01 (n = 6) 2.25 + 0.05 (n = 2)
slaty eye 0.97 + 0.03 (n = 6) 0.50 E 0.16 (n = 5)
same animals is a strong indication that the slaty locus does
indeed encode TRP-2/DT.
Discussion
We have described here the identification of a third member
of the tyrosinase protein family, TRP-2/DT. This appears
to be an old family. The genes are dispersed and located
on three different chromosomes, with no obvious
chromosomal relationships. The overall amino acid identity
between family members is of the order of 40%, which is
scattered throughout the proteins. Figure 5 shows a
comparison between the amino acid sequences of all three.
Examination of silent base substitutions at codons for
conserved amino acids suggests that the substitutions have
reached saturation; that is, the genes have been evolving
independently for a sufficiently long time that the only nucleic
acid identity seen is that which is required for amino acid
identity, and no relics remain of the ancestral gene. Further,
when the gene structures of tyrosinase and TRP-1 are
compared, their intron/exon organizations are quite different
(Jackson et al., 1991), again suggesting an ancient
duplication. A clearer idea of the age of the gene triplication
will be obtained by looking at the family in other species.
We examined the amino acid sequence of TRP-2/DT using
the programme Prosearch (L. F. Kowalski, MIT) to compare
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Fig. 5. Sequence comparison of tyrosinase-related protein family. The sequences of mouse tyrosinase (top row), TRP-2/DT (middle) and TRP-1
(lower) aligned to maximize amino acid similarity. Identical amino acids are indicated by and amino acids with chemically similar properties by :.
The 15 conserved cysteine residues are shaded, the two copper binding sites are boxed and the hydrophobic transmembrane domain is enclosed by
brackets.
with the Prosite database of motifs of Bairoch (1991) and
to carry out a sequence comparison with the protein sequence
database using the distributed array processor. We have
found that the first cysteine-rich domain is a previously
unreported member of the 'EGF-like' family. This
widespread motif consists of a number of cysteines, aromatic
residues, and glycines in a characteristically spaced pattern
(reviewed by Davis, 1990). Figure 6 shows the comparison
between the TRP region (from mouse and human tyrosinase
and TRP-1 in addition to TRP-2/DT) and consensuses of
different members of the EGF family. Some of these have,
like the TRPs, only a single related cysteine-rich region.
These proteins include numerous growth factors, such as
EGF itself, TGF-a and vaccinia growth factor. The blood
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Tyrosinase-related protein-2 is the slaty gene product
TRPs [xl]
laminin B1 [x13]
laminin A [x20]
laminin B2 [x12]
tenascin [xl 3]
serrate [xl 3]
Notch [x36]
lin -12 [x13]
growth factors [xl]
clotting factors [x2]
C
C
C
C
C
C
C
C
X -
X -
X 1-2
X 1-2
X5
x5
x 5
X 5 9
X 4-5
X 5
C
C
C
C
C
C
C
C
C
Ci
X X X
x x x
x x x
XX
x8
XX X
X X G FX
X X G X X
X X G X X
X X G X X
X X G X
X X G F/y X
X X X F/y X
X X x F/y x
F/y X
X X X F/y X
C
C
C
C
C
C
C
C
C
IC
x x
x x
x x
x x
X -
X -
X -
X -
X -
Ix-
C
C
C
C
C
C
x x
x x
x x
x x
x x
x x
x x
x x
x x
x x
G F40V
G F/y
G F/y
G F/y
G F/y
G F/y
G F/y
G F/y
G F/y
G F
X G X X
X G x 313
X G X3-17
X X XS5-11
X G X X
X G X X
X G X X
X G X X
X G X X
X G X X
C
C
C
C
C
C
C
C
C
Fig. 6. Comparison of the tyrosinase-related protein EGF domain. Alignment of amino acid sequences of some of the proteins containing the EGF
domain. The single-letter amino acid code is used, X = any amino acid residue, - = gap introduced to maximize alignment. The key conserved
residues are enclosed by a box. References to all sequences can be found in Davis (1990), except serrate, which is Fleming et al. (1990) and
Thomas et al. (1991).
clotting factors X and XI have two motifs, whilst others have
many copies, over 30 in some cases.
The best match to the TRP EGF domain is with the
multiple repeats in the extracellular matrix proteins, laminins
A, Bl and B2. The spacing of the conserved cysteines, in
addition to conserved glycine and aromatic residues is
identical between the TRPs and the laminin repeats. Other
extracellular proteins such as tenascin, fibulin and entactin
have repeats in which some of the spacings are slightly
different from the TRPs, but nevertheless are clearly related.
Also related are a number of Drosophila developmental gene
products, such as Notch, Delta, crumbs, serrate and slit,
and the nematode developmental genes lin-12 and glp.
The function of the EGF repeat is enigmatic. The pattern
of disulphide bridges between cysteines, where it has been
determined, is always 1-3, 2-4 and 5-6 (the first cysteine
in Figure 6 is number 2). The two classic mouse mutations
in tyrosinase (albino) and TRP-1 (brown) are substitutions
of cysteines 5 and 4 respectively in this motif, and a recently
characterized human albinism mutation has been found in
cysteine 2 (Jackson and Bennett, 1990; Zdarsky et al., 1990;
Spritz et al., 1991)
A common thread between the families which contain the
EGF motif appears to be that all are extracellular proteins
which may participate in protein-protein interaction. The
TRPs are not extracellular, but rather are most likely bound
to the inner (lumenal) face of the melanosome, the subcellular
site of pigment synthesis. We propose that all three family
members co-localize in the membrane, where they form a
multi-enzyme complex which undertakes eumelanin
synthesis. The EGF repeat is perhaps required for interaction
between the proteins and the formation of the complex. In
support of this notion Pawelek et al. (1991) have recently
demonstrated that a high molecular weight complex can be
isolated from melanosomes which contains tyrosinase, gp75
(human TRP-1) and DT (TRP-2). They have also
demonstrated MSH-receptor function in this complex. It
remains to be seen whether additional proteins participate.
The point mutation we identify is a strong candidate for
the slaty mutation, and make it highly likely that TRP-2/DT
is encoded at the slaty locus. Further genetic analysis of the
locus is limited; the slaty mutation is the only mutant allele
known. Nor is the background strain of origin of the mutation
known. The arginine to glutamine mutation in the slaty
TRP-2/DT is located in the first copper binding site of the
protein. This amino acid residue is only moderately
conserved between family members. The equivalent residue
is also arginine in mouse TRP-1 and tyrosinase, and is the
similarly basic amino acid lysine in human TRP-1, but in
human tyrosinase the equivalent residue is methionine. To
date, nine different missense mutations have been identified
in human tyrosinase which produce type IA albinism (a
complete loss of tyrosinase activity) (Giebel et al., 1990;
Kikuchi et al., 1990; Spritz et al., 1990, 1991; Takeda
et al., 1990; Oetting et al., 1991a,b). All nine change amino
acids which are identical across all five members of the
tyrosinase-related family (two human and three mouse). In
addition, the two loss-of-function cysteine mutations in
mouse tyrosinase and TRP-1 are conserved across the whole
family (Zdarsky et al., 1990; Jackson and Bennett, 1990).
By contrast, the two characterized mutations which lead to
type IB (yellow) albinism, and which, like the TRP-2/DT
slaty mutation do not give a complete loss-of-function, are
in amino acid residues which, as in the slaty mutation, are
only conserved across some of the family members (Giebel
et al., 1991).
Can the dark grey/brown phenotype of homozygous slaty
mice be rationalized by the reduction of DT activity? In the
absence of the enzyme DOPAchrome spontaneously converts
to DHI. Ito (1986) has shown by acid degradation of
melanins that melanins formed by tyrosinase alone in vitro
contain - 10% DHICA, the rest being mostly DHI. By
contrast, analysis of natural melanins, from melanoma cells
or from black hair, consists of at least 50% DHICA. We
have shown (Tsukamoto et al., 1992) that little or no DHICA
is made from DOPAchrome in vitro in the absence of DT,
whether spontaneously or in the presence of tyrosinase alone.
It seems likely that it is a difference in DHICA content which
results in the different colours of wild-type (black) versus
slaty eumelanin. The colour difference is a subtle one, which
probably reflects the residual DT activity in slaty animals.
It will be interesting to create null mutations of TRP-2/DT
to observe their effects on pigmentation, and also to see if
absence of DT activity has any other phenotypic effect on
development. It is possible that complete lack of DT might
have a severe effect on viability of melanocytes; DHI is quite
a cytotoxic metabolite (Pawelek and Lerner, 1978; Pawelek
et al., 1980), while DHICA appears to be somewhat less
toxic (unpublished).
In summary, we have identified a novel tyrosinase-related
protein, shown that it maps to and is mutated at the coat
colour locus, slaty, and shown that the mutant protein is
deficient for DOPAchrome tautomerase activity. The
identification of the mutant will be invaluable for further
studies of the protein's function, and for further dissection
of the development of melanocyte function.
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Materials and methods
Isolation and sequencing of TRP-2 cDNAs
The identification of cloneSA as a Xgtl clone reacting with two different
tyrosinase antisera has been described (Jackson, 1988). The 1.2 kb EcoRI
insert was subcloned in both orientations into pBS. A series of deletion
derivatives of the plasmids were made by exonuclease digestions from one
end using the Erase-a-Base kit from Promega. These were sequenced using
Sequenase (USB) according to the manufacturer's instructions. The 330 bp
insert from a deletion plasmid, representing the5'-most deletion product
was used to rescreen the Xgt11 library by DNA hybridization in order to
identify full-length cDNA clones. The two EcoRI fragments of the largest
clone were subcloned separately into pBS.
The longer fragment was reduced to deletion derivatives as above and
sequenced. Oligonucleotide primers were synthesized which would prime
sequencing along the whole length of the cDNA. These corresponded to
bases in Figure as follows:
coding strand complementary: 355 -373; 543 -562; 781-801;
1101 -1120; 1306-1325; 1462-1483; 1642-1661; 1788-1807;
non-coding strand complementary: 565 -546; 781 -762; 1100-1081;
1305-1286; 1461-1442; 1641-1623; 1787-1769; 2025-2006.
These primers were used to confirm the sequence of the full-length clone.
The same primers were also used to prime the polymerase chain reaction
(PCR) from cDNA synthesized using a kit from Boehringer-Mannheim and
total RNA from neonatal wild-type or slaty mouse skin (Saiki et al., 1988;
Jackson et al., 1990). A PCR was performed using the outermost primer
pair. The 1671 bp fragment thus amplified was isolated from an agarose
gel using Geneclean and was reamplified using primer pairs separated by
400-560 bp to generate overlapping amplified fragments. These were again
gel-purifed and sequenced according to the method of Winship (1989) using
the PCR-priming oligonucleotides and the internal pair.
RNA isolation and analysis
RNA was isolated from neonatal mouse skin as described (Jackson et al.,
1990) using the LiCI/urea method. Formaldehyde-agarose gel analysis was
as described. The RNA was blotted onto nitrocellulose and hybridized with
the SA insert as described.
Interspecific backcross mapping
Interspecific backcross progeny were generated by mating
(C57BL/6J XM.spretus)Fl females and C57BL/6J males as described
(Copeland and Jenkins, 1991). A total of 205 N2 progeny were obtained;
a random subset of these N2 mice were used to map the Tyrp-2 locus (see
text for details). DNA isolation, restriction enzyme digestion, agarose gel
electrophoresis, Southern blot transfer and hybridization were performed
essentially as described (Jenkins et al., 1982). All blots were prepared with
Zetabind nylon membrane (AMF-Cuno). The Tyrp-2 probe, the 1.2 kb
EcoRI fragment from the cDNA clone SA, was labelled with [a-32P]dCTP
using a nick translation kit (Boehringer Mannheim). Fragments of 8.9, 4.8,
3.9 and 2.2 kb were detected in Pvull-digested C57BL/6J DNA; fragments
of 7.6, 4.1 and 2.0 kb were detected in PvuII-digested M.spretus DNA.
The 7.6, 4.1 and 2.0 kb Mspretus-specific fragments cosegregated and were
followed in this analysis. A description of the probes and RFLPs for the
bone morphogenetic protein-I (Bmp-J) and hairless (hr) loci has been
reported previously (Ceci et al., 1990). The probe for DNA segment, chr
14 Ehl I (DJ4Ehll) locus was a 900 bp mouse cDNA that detected a 2.5 kb
TaqI fragment in C57BL/6J DNA and a 4.2 kb fragment in M.spretus DNA.
The probe was kindly provided by Elizabeth Lacy (Sloan-Kettering Institute,
New York, NY). Recombination distances were calculated as described
(Green, 1981) using the computer program SPRETUS MADNESS. Gene
order was determined by minimizing the number of recombination events
required to explain the allele distribution patterns.
Protein methods
Production of the PEP8 antibody is described in Tsukamoto et al. (1992).
Melan-a melanocytes and B 16 and MNT1 melanoma cells were grown as
previously described. For metabolic labelling they were pulsed for 30 min
with [35S]methionine and chased for 60 min, harvested by trypsinization
and solubilized in 1% Nonidet-P40, 0.01% SDS, 0.1 M Tris-HCI, pH
7.2, 1 jtg/ml aprotinin and 100 mM PMSF as detailed in Tsukamoto et al.
(1992). Immunoprecipitation with antibodies was as described, and reactive
proteins were electrophoresed through 7.5% Laemmli polyacrylamide gels
(Laemmli, 1970). and visualized by treatment with Autofluor (National
Diagnostics, Manville NJ) and autoradiography on Kodak XAR-2 film.
Proteins were electroblotted onto nitrocellulose filters, reacted with 1: 1000
dilutions of aPEP8 or non-immune serum and the antibodies detected with
the avidin -biotin system coupled to alkaline phosphatase (Tsukamoto et al.,
1992).
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Tyrosinase and DOPAchrome tautomerase activity was assayed in tissue
extracts as described in Tsukamoto et al. (1992)
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